GCANPharmaceutical PreparationsFiscal year ends December 31Also trades as GCAND
TRAFALGAR INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.14+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.13M
- P/E (TTM)
- –
- Dividend yield
- –
TRAFALGAR INTERNATIONAL, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|
| Product [Member] | $12.63K | $48.04K | $4.50K | 100.0% | -73.7% |
| Consulting Fees [Member] | – | – | $2.62K | – | – |
By region
From the segment and revenue-disaggregation notes of Trafalgar International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.